Kumiko Shimozawa

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

Tetsuhiro Tsuruma, Fumitake Hata, Toshihiko Torigoe et al. · Journal of Translational Medicine · 2004 · 181 citations · Full text

Medicine, Immunology, Oncology +17

Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5

Tomohide Tsukahara, Satoshi Kawaguchi, Toshihiko Torigoe et al. · Cancer Science · 2006 · 143 citations · Full text

Life Sciences, Medicine, Immunology +18

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma

Satoshi Kawaguchi, Takuro Wada, Kazunori Ida et al. · Journal of Translational Medicine · 2005 · 138 citations · Full text

Life Sciences, Immunology, Oncology +17

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

Tetsuhiro Tsuruma, Yuji Iwayama, Tosei Ohmura et al. · Journal of Translational Medicine · 2008 · 84 citations · Full text

Medicine, Immunology, Oncology +17

Identification of Human Autologous Cytotoxic T-Lymphocyte-Defined Osteosarcoma Gene That Encodes a Transcriptional Regulator, Papillomavirus Binding Factor

Tomohide Tsukahara, Yuki Nabeta, Satoshi Kawaguchi et al. · Cancer Research · 2004 · 70 citations

Life Sciences, Molecular Biology, Oncology +16